Melatonin Products

Melatonin Products

Global Melatonin Products Market to Reach US$4.5 Billion by 2030

The global market for Melatonin Products estimated at US$2.0 Billion in the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 12.4% over the analysis period 2023-2030. Synthetic Melatonin Products, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Natural Melatonin Products segment is estimated at 13.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$537.0 Million While China is Forecast to Grow at 16.6% CAGR

The Melatonin Products market in the U.S. is estimated at US$537.0 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$972.4 Million by the year 2030 trailing a CAGR of 16.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.4% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

Global Melatonin Products Market - Key Drivers and Trends Summarized

Melatonin products are dietary supplements and over-the-counter medications designed to regulate sleep-wake cycles. Melatonin, a hormone naturally produced by the pineal gland in the brain, plays a critical role in controlling the circadian rhythm, which dictates our sleep patterns. These products come in various forms, including tablets, gummies, liquids, and sprays, and are widely used to address issues such as insomnia, jet lag, and delayed sleep phase syndrome. The supplements are especially popular among individuals who have difficulty falling asleep or maintaining a regular sleep schedule due to lifestyle factors or medical conditions.

The market for melatonin products has seen substantial growth in recent years, driven by an increasing prevalence of sleep disorders and a growing awareness of the importance of sleep for overall health. Advances in medical research have highlighted the adverse effects of sleep deprivation, including its impact on mental health, cognitive function, and chronic disease risk. As a result, consumers are more inclined to seek natural and non-prescription remedies like melatonin supplements to improve their sleep quality. Additionally, the aging population, which is more susceptible to sleep disturbances, has contributed to the rising demand for these products. The availability of melatonin in various convenient forms has also made it easier for consumers to incorporate it into their nightly routines.

The growth in the melatonin products market is driven by several factors, including advancements in delivery methods, increasing consumer preference for natural sleep aids, and expanding applications in pediatric and geriatric care. Technological innovations have led to the development of sustained-release formulations that provide a more consistent melatonin level throughout the night, enhancing efficacy and user satisfaction. Consumer behavior trends indicate a shift towards natural and holistic health solutions, with many people opting for melatonin over prescription sleep medications due to its perceived safety and lower risk of dependency. Furthermore, the application of melatonin in pediatric care to address sleep issues in children with neurodevelopmental disorders and in geriatric care for age-related sleep disturbances has broadened its market scope. The growing body of research supporting the benefits of melatonin in managing sleep disorders, coupled with increased marketing efforts by supplement manufacturers, is expected to continue driving the market`s expansion.

Select Competitors (Total 86 Featured) -

• 21st Century HealthCare, Inc.
• Aspen Pharmacare Australia Pty Ltd.
• B Joshi Agrochem Pharma Pvt Ltd
• BioTech Pharmacal, Inc.
• Biotics Research Corporation
• Bluebonnet Nutrition Corporation
• Carlson Laboratories, Inc.
• Church & Dwight Co., Inc.
• Douglas Laboratories
• Jamieson Laboratories Ltd.
• Natrol LLC
• Pfizer Inc
• Pharmavite, LLC
• Rexall Sundown, Inc.
• Solgar Inc.;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.